Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors

Biomaterials

Volumn 31, Issue 32, 2010, Pages 8393-8401

  Roger, Mathilde ^a   Clavreul, Anne ^a,b   Venier Julienne, Marie Claire ^a   Passirani, Catherine ^a   Sindji, Laurence ^a   Schiller, Paul ^c   Montero Menei, Claudia ^a   Menei, Philippe ^a,b  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cellular vehicle; Glioma; Mesenchymal stem cells; Nanoparticles

Indexed keywords

BRAIN TUMORS; CELL VIABILITY; CELLULAR VEHICLE; COUMARIN 6; DELIVERY VEHICLE; GLIOMA; LIPID NANOCAPSULES; MALIGNANT GLIOMA; MESENCHYMAL STEM CELL; POLY LACTIC ACID; PROOF OF CONCEPT; SUSTAINED RELEASE; THERAPEUTIC AGENTS; TUMOR-SPECIFIC TARGETING;

CELL CULTURE; FLOWCHARTING; LACTIC ACID; NANOPARTICLES; ORGANIC ACIDS; TUMORS; VEHICLES;

STEM CELLS;

DRUG VEHICLE; ESCULIN; NANOCAPSULE; NANOPARTICLE; POLYLACTIC ACID;

ARTICLE; CANCER DIAGNOSIS; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; DRUG DELIVERY SYSTEM; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; NANOTECHNOLOGY; OUTCOME ASSESSMENT; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GLIOMA; HUMANS; LACTIC ACID; LIPIDS; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; NANOCAPSULES; NANOPARTICLES; POLYMERS;

EID: 77956182174     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.07.048     Document Type: Article

References (53)

1. Westphal M., Hilt D.C., Bortey E., Delavault P., Olivares R., Warnke P.C., et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 2003, 5(2):79-88.
2. Stupp R., Hegi M.E., van den Bent M.J., Mason W.P., Weller M., Mirimanoff R.O., et al. Changing paradigms-an update on the multidisciplinary management of malignant glioma. Oncologist 2006, 11(2):165-180.
3. Huynh N.T., Passirani C., Saulnier P., Benoit J.P. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 2009, 379(2):201-209.
4. Garcion E., Lamprecht A., Heurtault B., Paillard A., Aubert-Pouessel A., Denizot B., et al. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther 2006, 5(7):1710-1722.
5. Kumari A., Yadav S.K., Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010, 75(1):1-18.
6. Hamoudeh M., Kamleh M.A., Diab R., Fessi H. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer. Adv Drug Deliv Rev 2008, 60(12):1329-1346.
7. Morille M., Montier T., Legras P., Carmoy N., Brodin P., Pitard B., et al. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials 2010, 31(2):321-329.
8. Prabha S., Labhasetwar V. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharm Res 2004, 21(2):354-364.
9. Sarin H. Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors. J Transl Med 2009, 7:77.
10. Shah N., Chaudhari K., Dantuluri P., Murthy R.S., Das S. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model. J Drug Target 2009, 17(7):533-542.
11. Pardridge W.M. Molecular biology of the blood-brain barrier. Mol Biotechnol 2005, 30(1):57-70.
12. Beduneau A., Hindre F., Clavreul A., Leroux J.C., Saulnier P., Benoit J.P. Brain targeting using novel lipid nanovectors. J Control Release 2008, 126(1):44-49.
13. Bobo R.H., Laske D.W., Akbasak A., Morrison P.F., Dedrick R.L., Oldfield E.H. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 1994, 91(6):2076-2080.
14. Allard E., Passirani C., Benoit J.P. Convection-enhanced delivery of nanocarriers for the treatment of brain tumors. Biomaterials 2009, 30(12):2302-2318.
15. Allard E., Huynh N.T., Vessieres A., Pigeon P., Jaouen G., Benoit J.P., et al. Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model. Int J Pharm 2009, 379(2):317-323.
16. Vinchon-Petit S., Jarnet D., Paillard A., Benoit J.P., Garcion E., Menei P. In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy. J Neurooncol 2010, 97(2):195-205.
17. Motaln H., Schichor C., Lah T.T. Human mesenchymal stem cells and their use in cell-based therapies. Cancer 2010, 116(11):2519-2530.
18. Kosztowski T., Zaidi H.A., Quinones-Hinojosa A. Applications of neural and mesenchymal stem cells in the treatment of gliomas. Expert Rev Anticancer Ther 2009, 9(5):597-612.
19. Nakamura K., Ito Y., Kawano Y., Kurozumi K., Kobune M., Tsuda H., et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004, 11(14):1155-1164.
20. Nakamizo A., Marini F., Amano T., Khan A., Studeny M., Gumin J., et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005, 65(8):3307-3318.
21. Miletic H., Fischer Y., Litwak S., Giroglou T., Waerzeggers Y., Winkeler A., et al. Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol Ther 2007, 15(7):1373-1381.
22. Xu J., Qu J., Cao L., Sai Y., Chen C., He L., et al. Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol 2008, 214(4):472-481.
23. Menon L.G., Kelly K., Yang H.W., Kim S.K., Black P.M., Carroll R.S. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells 2009, 27(9):2320-2330.
24. Stoff-Khalili M.A., Rivera A.A., Mathis J.M., Banerjee N.S., Moon A.S., Hess A., et al. Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat 2007, 105(2):157-167.
25. Sonabend A.M., Ulasov I.V., Tyler M.A., Rivera A.A., Mathis J.M., Lesniak M.S. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells 2008, 26(3):831-841.
26. D'Ippolito G., Howard G.A., Roos B.A., Schiller P.C. Isolation and characterization of marrow-isolated adult multilineage inducible (MIAMI) cells. Exp Hematol 2006, 34(11):1608-1610.
27. D'Ippolito G., Diabira S., Howard G.A., Menei P., Roos B.A., Schiller P.C. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 2004, 117(Pt 14):2971-2981.
28. Venier-Julienne M.C., Benoit J.P. Preparation, purification and morphology of polymeric nanoparticles as drug carriers. Pharm Acta Helv 1996, 71(2):121-128.
29. Heurtault B., Saulnier P., Pech B., Proust J.E., Benoit J.P. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 2002, 19(6):875-880.
30. Fery-Forgues S., El-Ayoubi R., Lamere J.F. Fluorescent microcrystals obtained from coumarin 6 using the reprecipitation method. J Fluoresc 2008, 18(3-4):619-624.
31. Van Amersfoort E.S., Van Strijp J.A. Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes. Cytometry 1994, 17(4):294-301.
32. Jain K.K. Use of nanoparticles for drug delivery in glioblastoma multiforme. Expert Rev Neurother 2007, 7(4):363-372.
33. Andrieux K., Couvreur P. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1(5):463-474.
34. Laquintana V., Trapani A., Denora N., Wang F., Gallo J.M., Trapani G. New strategies to deliver anticancer drugs to brain tumors. Expert Opin Drug Deliv 2009, 6(10):1017-1032.
35. Khalil N.M., Mainardes R.M. Colloidal polymeric nanoparticles and brain drug delivery. Curr Drug Deliv 2009, 6(3):261-273.
36. Valable S., Barbier E.L., Bernaudin M., Roussel S., Segebarth C., Petit E., et al. In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma. Neuroimage 2008, 40(2):973-983.
37. Alizadeh D., Zhang L., Hwang J., Schluep T., Badie B. Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas. Nanomedicine 2009, 6(2):382-390.
38. Jiang Y., Vaessen B., Lenvik T., Blackstad M., Reyes M., Verfaillie C.M. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002, 30(8):896-904.
39. Kim S.M., Lim J.Y., Park S.I., Jeong C.H., Oh J.H., Jeong M., et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 2008, 68(23):9614-9623.
40. Glover D.J., Lipps H.J., Jans D.A. Towards safe, non-viral therapeutic gene expression in humans. Nat Rev Genet 2005, 6(4):299-310.
41. Ferreira E., Potier E., Logeart-Avramoglou D., Salomskaite-Davalgiene S., Mir L.M., Petite H. Optimization of a gene electrotransfer method for mesenchymal stem cell transfection. Gene Ther 2008, 15(7):537-544.
42. Rosen A.B., Kelly D.J., Schuldt A.J., Lu J., Potapova I.A., Doronin S.V., et al. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 2007, 25(8):2128-2138.
43. Huang D.M., Hung Y., Ko B.S., Hsu S.C., Chen W.H., Chien C.L., et al. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. Faseb J 2005, 19(14):2014-2016.
44. Yang F., Cho S.W., Son S.M., Bogatyrev S.R., Singh D., Green J.J., et al. Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci U S A 2010, 107(8):3317-3322.
45. Tatard V.M., D'Ippolito G., Diabira S., Valeyev A., Hackman J., McCarthy M., et al. Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons. Bone 2007, 40(2):360-373.
46. Shive M.S., Anderson J.M. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997, 28(1):5-24.
47. Beduneau A., Saulnier P., Anton N., Hindre F., Passirani C., Rajerison H., et al. Pegylated nanocapsules produced by an organic solvent-free method: evaluation of their stealth properties. Pharm Res 2006, 23(9):2190-2199.
48. Mailander V., Lorenz M.R., Holzapfel V., Musyanovych A., Fuchs K., Wiesneth M., et al. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol Imaging Biol 2008, 10(3):138-146.
49. Lorenz M.R., Holzapfel V., Musyanovych A., Nothelfer K., Walther P., Frank H., et al. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials 2006, 27(14):2820-2828.
50. Gratton S.E., Ropp P.A., Pohlhaus P.D., Luft J.C., Madden V.J., Napier M.E., et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A 2008, 105(33):11613-11618.
51. Panyam J., Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(d, l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 2003, 20(2):212-220.
52. Lazennec G., Jorgensen C. Concise review: adult multipotent stromal cells and cancer: risk or benefit?. Stem Cells 2008, 26(6):1387-1394.
53. Francois S., Bensidhoum M., Mouiseddine M., Mazurier C., Allenet B., Semont A., et al. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells 2006, 24(4):1020-1029.